BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27665479)

  • 1. The Quality of Staging Non-Small Cell Lung Cancer in the Netherlands: Data From the Dutch Lung Surgery Audit.
    Heineman DJ; Ten Berge MG; Daniels JM; Versteegh MI; Marang-van de Mheen PJ; Wouters MW; Schreurs WH
    Ann Thorac Surg; 2016 Nov; 102(5):1622-1629. PubMed ID: 27665479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Staging of Stage I Non-Small Cell Lung Cancer in the Netherlands-Need for Improvement in an Era With Expanding Nonsurgical Treatment Options: Data From the Dutch Lung Surgery Audit.
    Heineman DJ; Ten Berge MG; Daniels JM; Versteegh MI; Marang-van de Mheen PJ; Wouters MW; Schreurs WH
    Ann Thorac Surg; 2016 Nov; 102(5):1615-1621. PubMed ID: 27665481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dutch national clinical audit for lung cancer: A tool to improve clinical practice? An analysis of unforeseen ipsilateral mediastinal lymph node involvement in the Dutch Lung Surgery Audit (DLSA).
    Heineman DJ; Beck N; Wouters MW; van Brakel TJ; Daniels JM; Schreurs WH; Dickhoff C
    Eur J Surg Oncol; 2018 Jun; 44(6):830-834. PubMed ID: 29396329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.
    Stiles BM; Servais EL; Lee PC; Port JL; Paul S; Altorki NK
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):13-9. PubMed ID: 19154893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with true pathologic stage I non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
    Bryant AS; Cerfolio RJ
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1363-8. PubMed ID: 17140957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
    Kremer R; Peysakhovich Y; Dan LF; Guralnik L; Kagna O; Nir RR; Bar-Shalom R
    Ann Nucl Med; 2016 Feb; 30(2):114-21. PubMed ID: 26613715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When is it best to repeat a 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy?
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2007 Oct; 84(4):1092-7. PubMed ID: 17888953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
    D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
    Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of EUS-guided fine needle aspiration and integrated PET-CT in restaging after treatment for locally advanced non-small cell lung cancer.
    Stigt JA; Oostdijk AH; Timmer PR; Shahin GM; Boers JE; Groen HJ
    Lung Cancer; 2009 Nov; 66(2):198-204. PubMed ID: 19231024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of flexible bronchoscopy for the preoperative assessment of NSCLC diagnosed using percutaneous core needle biopsy.
    Jo KW; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Choi CM
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):593-8. PubMed ID: 25025892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of clinical and surgico-pathological TNM stage of 2007 lung cancer patients].
    Huang GJ; Zhang DC; Mao YS; Li J; Wang YG; Wang DL; Xue Q; Gao SG; Zhang LZ; Lei WD; Gao YS; Zhao J; Huang JF; Yang K; Su K; Zhu SY; Wei S; Feng FY
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):551-3. PubMed ID: 16438855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
    Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
    Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
    Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.
    Turk F; Gursoy S; Yaldiz S; Yuncu G; Yazgan S; Basok O
    Minerva Chir; 2011 Dec; 66(6):509-16. PubMed ID: 22233657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.